Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases

Launched by XIJING HOSPITAL · Jun 11, 2011

Keywords

ClinConnect Summary

This clinical trial is studying a protein called adiponectin, which is found in the body and may be linked to heart and brain health. Researchers want to understand how levels of this protein in the blood relate to conditions like heart attacks and strokes in the Chinese population. This study will follow participants for five years to gather important information about how adiponectin behaves and its potential impact on these diseases.

To be eligible for this study, participants should be between 65 and 74 years old and be able to commit to the five-year follow-up. Certain individuals are not eligible, including those who are pregnant, have active liver disease, or have severe kidney issues. Participants can expect regular check-ups and tests over the study period, which will help researchers learn more about the relationship between adiponectin and cardiovascular health. This trial is currently recruiting participants, and it aims to uncover valuable insights that could improve health outcomes for people at risk of heart and brain problems.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • available for 5 years of follow-up study
• Exclusion Criteria:
• • Death caused other than cardiovascular and cerebralvascular diseases till the study ends
• • Floating Population
• • Pregnancy, lactation, or child bearing women
• • Tumor
• • Active hepatic disease or hepatic dysfunction, or AST/ALT \> 1.5UNL
• • Severe renal dysfunction(Scr \> 3 mg/dl or 264μmol/L)
• • Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding